Newbridge Financial Services Group Inc. Buys 419 Shares of SPDR S&P Biotech ETF (NYSEARCA:XBI)

Newbridge Financial Services Group Inc. raised its stake in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 3.4% during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 12,600 shares of the exchange traded fund’s stock after purchasing an additional 419 shares during the period. Newbridge Financial Services Group Inc.’s holdings in SPDR S&P Biotech ETF were worth $1,168,000 as of its most recent SEC filing.

Other institutional investors also recently modified their holdings of the company. Sanctuary Advisors LLC bought a new position in SPDR S&P Biotech ETF in the 2nd quarter worth $1,247,000. LHM Inc. grew its position in shares of SPDR S&P Biotech ETF by 106.5% in the second quarter. LHM Inc. now owns 77,242 shares of the exchange traded fund’s stock valued at $7,161,000 after purchasing an additional 39,828 shares during the last quarter. Granite Bay Wealth Management LLC increased its stake in shares of SPDR S&P Biotech ETF by 4,965.8% in the second quarter. Granite Bay Wealth Management LLC now owns 124,062 shares of the exchange traded fund’s stock worth $11,097,000 after purchasing an additional 121,613 shares during the period. Ted Buchan & Co acquired a new position in shares of SPDR S&P Biotech ETF during the 2nd quarter worth about $8,857,000. Finally, Truist Financial Corp lifted its position in shares of SPDR S&P Biotech ETF by 0.8% during the 2nd quarter. Truist Financial Corp now owns 32,773 shares of the exchange traded fund’s stock worth $3,038,000 after purchasing an additional 252 shares during the last quarter.

SPDR S&P Biotech ETF Stock Down 0.8 %

XBI opened at $97.97 on Wednesday. The stock’s 50 day moving average price is $98.90 and its two-hundred day moving average price is $93.99. The firm has a market capitalization of $7.47 billion, a P/E ratio of 11.47 and a beta of 1.11. SPDR S&P Biotech ETF has a 12-month low of $63.80 and a 12-month high of $103.52.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.